Comparative Analysis of NTG-Pd/Pa and Saline-Pd/Pa (CANS)

NCT07195968 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-09-29

No results posted yet for this study

Summary

The goal of this observational study is to compare the value of NTG-Pd/Pa and saline-Pd/Pa in participants with intermediate stenosis of the coronary artery. The main questions it aims to answer are:

The numerical difference between NTG-Pd/Pa and saline-Pd/Pa To compare the diagnostic performance of NTG-Pd/Pa and saline-Pd/Pa in predicting the binary result of FFR assessment?

Participants will undergo NTG-Pd/Pa, Saline-Pd/Pa, and FFR successively in the target vessel.

Conditions

Interventions

DIAGNOSTIC_TEST

NTG-Pd/Pa measurement

The coronary artery with intermediate stenosis will sequentially undergo NTG-Pd/Pa, saline-Pd/Pa, and FFR assessments. Intracoronary NTG dosage will follow the protocol based on blood pressure.

DIAGNOSTIC_TEST

Saline-Pd/Pa measurement

The coronary artery with intermediate stenosis will sequentially undergo NTG-Pd/Pa, saline-Pd/Pa, and FFR assessments. Ten millilitres of intracoronary saline will be given over five seconds.

Sponsors & Collaborators

  • Miaoli General Hospital, Ministry of Health and Welfare, Taiwan

    collaborator UNKNOWN
  • Taichung Veterans General Hospital

    collaborator OTHER
  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chien Boon Jong, MD · National Taiwan University Hospital, Hsin-Chu Hospital

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-17
Primary Completion
2027-05-31
Completion
2029-12-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07195968 on ClinicalTrials.gov